Correlation Between Acumen Pharmaceuticals and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Entero Therapeutics,, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Entero Therapeutics,.
Diversification Opportunities for Acumen Pharmaceuticals and Entero Therapeutics,
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acumen and Entero is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Entero Therapeutics,
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.82 times more return on investment than Entero Therapeutics,. However, Acumen Pharmaceuticals is 1.22 times less risky than Entero Therapeutics,. It trades about -0.12 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.22 per unit of risk. If you would invest 280.00 in Acumen Pharmaceuticals on August 23, 2024 and sell it today you would lose (49.00) from holding Acumen Pharmaceuticals or give up 17.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Entero Therapeutics,
Performance |
Timeline |
Acumen Pharmaceuticals |
Entero Therapeutics, |
Acumen Pharmaceuticals and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Entero Therapeutics,
The main advantage of trading using opposite Acumen Pharmaceuticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.The idea behind Acumen Pharmaceuticals and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Entero Therapeutics, vs. ZyVersa Therapeutics | Entero Therapeutics, vs. Sonnet Biotherapeutics Holdings | Entero Therapeutics, vs. Zura Bio Limited | Entero Therapeutics, vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |